Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

CMS Releases Proposed Decision Memo for Tricuspid TEER

L.A. McKeown

April 04, 2025

News Daily News

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

L.A. McKeown

February 24, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

L.A. McKeown

April 02, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

News Daily News

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

L.A. McKeown

August 21, 2023

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Daily News

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

L.A. McKeown

November 21, 2022

News Daily News

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

L.A. McKeown

September 22, 2021

Excluded from Pivotal Trials, Low-risk Complex Patients Warrant Caution

News Daily News

Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution

L.A. McKeown

January 22, 2021

News Daily News

Television Viewing Time Linked to Higher Mortality From Pulmonary Embolism

L.A. McKeown

July 25, 2016

News Daily News

肺栓塞发作后，二级抗凝效果未持续

L.A. McKeown

July 13, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

L.A. McKeown

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

News Daily News

一项批准后研究证实了经导管肺动脉瓣膜在现实人群中的安全性和疗效

L.A. McKeown

December 04, 2014

News Daily News

Un Estudio Postaprobación Confirma la Seguridad y Eficacia de la Válvula Pulmonar Transcatéter en el Mundo Real

L.A. McKeown

December 04, 2014

News Daily News

Postapproval Study Confirms Safety, Efficacy of Transcatheter Pulmonary Valve in Real World

L.A. McKeown

December 04, 2014

Advertisement

CMS Releases Proposed Decision Memo for Tricuspid TEER

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

Top Structural Heart News of 2024

FDA Approves TriClip TEER Device for Tricuspid Repair

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution

Television Viewing Time Linked to Higher Mortality From Pulmonary Embolism

肺栓塞发作后，二级抗凝效果未持续

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

一项批准后研究证实了经导管肺动脉瓣膜在现实人群中的安全性和疗效

Un Estudio Postaprobación Confirma la Seguridad y Eficacia de la Válvula Pulmonar Transcatéter en el Mundo Real

Postapproval Study Confirms Safety, Efficacy of Transcatheter Pulmonary Valve in Real World

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content